Assignee
IMMUNEERING CORP
US·3 granted patents·5 pending applications·2 citations·filing 2010–2025
Top patents by PatentIndex Score
8 records- 0165US11043305B1Systems and methods for rapid gene set enrichment analysisIMMUNEERING CORP·Filed 2019·Granted Jun 22, 2021·2 cites·19 claims
- 0258US12351566B2MEK inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2021·Granted Jul 8, 2025·0 cites·21 claims
- 0357US2025270180A1Mek inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 0453US11942223B1Systems and methods for rapid gene set enrichment analysisIMMUNEERING CORP·Filed 2021·Granted Mar 26, 2024·0 cites·48 claims
- 0551US2025179057A1Mek immune oncology inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2023·Application pending·0 cites
- 0649US2026060956A1Treating pancreatic cancerIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 0740US2016154928A1Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or conditionIMMUNEERING CORP·Filed 2014·Application pending·0 cites
- 0826US2010310511A1Determining disease or immune system features based on analysis of immune system characteristicsIMMUNEERING CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNEERING CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →